Contrast-Enhanced Mammography Shows Promise for Breast Cancer Surveillance

Contrast-enhanced mammography (CEM) has emerged as a promising tool for the surveillance of women with a personal history of breast cancer, according to research presented at the San Antonio Breast Cancer Symposium. CEM involves intravenous contrast dye that highlights blood vessels and increases the visibility of abnormalities in mammograms. This imaging technique has shown potential in detecting tumor recurrence or new cancers that may not be easily visible on standard mammograms. The study discussed by Julia Matheson from the University of California, San Francisco, encompasses the advantages and applications of CEM. Matheson highlighted that CEM has the potential to improve breast cancer detection rates and reduce false positive results, thus providing a significant advancement in breast cancer surveillance. The researchers also compared CEM to traditional imaging techniques like MRI and ultrasound, finding it to be less invasive and more cost-effective. While further studies and clinical trials are needed to validate these findings, this research sheds light on a promising avenue for enhancing breast cancer surveillance.